Approximately 20 million patients a year in the U.S. experience one or more forms of acute cardiac conditions. Current therapies are not optimal and result in poor patient quality of life, frequent ER visits and extended hospitalizations. These therapies also add a tremendous burden to the overall healthcare cost.
Here at InCarda, we see a better way. We see a future that includes improved quality of care for patients with acute cardiac conditions. We are committed to developing transformative therapies that patients can use themselves in the first moments of acute cardiovascular symptoms.
© 2011-2014 InCarda Therapeutics, Inc.